Nanomedicine, Imaging & Theranostics at World Nano 2027

Nanomedicine, biomedical imaging and theranostics are explored through disease-focused research at the World Nanotechnology Conference. This session covers cancer nanomedicine, chronic disease applications, antimicrobial approaches, molecular and multimodal imaging, and platforms that combine diagnostic and therapeutic functions. Discussions will examine how nanoscale systems are investigated in biological models and evaluated for potential medical use, including disease targeting, imaging performance, treatment response and translational challenges. The scope extends across different diseases and care settings without limiting contributions to one material class or therapeutic strategy.

Abstract Scope and Participation

Abstracts are invited on fundamental, preclinical and clinical research, imaging methods, disease models, theranostic platforms and evidence-based translational assessments. Contributions examining validation, biological performance and limitations are also encouraged. Biomedical researchers, clinicians, imaging specialists, materials scientists, pharmaceutical professionals and students are welcome to share findings and discuss the opportunities and challenges involved in developing nanotechnology for medical applications.